UroToday Interviews Dr. Steven Finkelstein on New Landmark Pre-Chemotherapy Treatment for Prostate Cancer after Delivering First Dose in U.S.
Zachary Klaassen speaks with Steven Finkelstein about the FDA approval of Pluvicto™ (177Lu-PSMA-617) in the pre-chemotherapy setting for metastatic castration-resistant prostate cancer. Dr. [...]
